Pay in 4 interest-free payments of $6.74 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
Tirzepatide is a once-weekly injectable medication approved by the FDA for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity
Tirzepatide, a relatively new and highly effective drug, has revolutionized the treatment of type 2 diabetes and obesity
Remove the syringe from the vial and apply a new seal sticker to the cap of the vial
The former enrolled 469 non diabetic obese individuals aged 47.951.7 years with moderate-to-severe OSA (mean BMI 38.739.1 kg/m 2 ) and showed a 17.719.6% BW reduction with the highest tolerated dose of tirzepatide vs
Figure 3B)
US$ 26.30
US$ 27.08
US$ 29.24
US$ 23.79
US$ 20.33
US$ 28.81
